Baidu
map

职称评审大放开!民办机构人才可申报正高

2018-02-06 侯文坤、罗鑫 新华网

湖北敞开非公技术人才高级职称评审渠道,民办与公立机构专业人才职称评审享有平等权利。

湖北敞开非公技术人才高级职称评审渠道,非国企专业技术人员可申报正高,科技、教育、医疗、文化等领域民办机构与公立机构的专业技术人才职称评审享有平等权利。

湖北省关于深化职称制度改革的实施意见日前发布,非公有制经济组织、社会组织、小微企业、自由职业专业技术人才和农民技术人才的申报渠道将进一步畅通,鼓励高校、科研院所、医疗机构等知识密集型单位的专业技术人才离岗创业,离岗创新创业或兼职期间工作业绩作为职称评审的依据。

此次出台的意见首次明确,在湖北省工作1年以上的专业技术人才均可按规定申报职称,此前尚未设置正高的实验技术、中专教师、工艺美术和部分专业均设置正高职称,对以往设置正高的工程、农业、经济、统计、会计、审计专业取消限制条件。

据了解,早在2003年湖北就对经济、统计、会计、审计专业设置了正高职称,2005年又对部分工程专业设置正高职称。但考虑到与事业单位岗位设置的有效衔接,经济、统计、会计、审计等专业的正高职称评审范围仅限国有企业,这次首次明确取消这些限制条件,符合条件的专业技术人员均有机会申报。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032165, encodeId=251a203216551, content=<a href='/topic/show?id=25538066177' target=_blank style='color:#2F92EE;'>#职称评审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80661, encryptionId=25538066177, topicName=职称评审)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Feb 17 08:02:00 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688544, encodeId=7a23168854438, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Wed Mar 21 00:02:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518309, encodeId=739a151830989, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Thu Feb 08 00:02:00 CST 2018, time=2018-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285628, encodeId=635a285628b8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Feb 06 09:15:07 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285625, encodeId=31ed28562588, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Feb 06 09:14:34 CST 2018, time=2018-02-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032165, encodeId=251a203216551, content=<a href='/topic/show?id=25538066177' target=_blank style='color:#2F92EE;'>#职称评审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80661, encryptionId=25538066177, topicName=职称评审)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Feb 17 08:02:00 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688544, encodeId=7a23168854438, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Wed Mar 21 00:02:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518309, encodeId=739a151830989, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Thu Feb 08 00:02:00 CST 2018, time=2018-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285628, encodeId=635a285628b8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Feb 06 09:15:07 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285625, encodeId=31ed28562588, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Feb 06 09:14:34 CST 2018, time=2018-02-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032165, encodeId=251a203216551, content=<a href='/topic/show?id=25538066177' target=_blank style='color:#2F92EE;'>#职称评审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80661, encryptionId=25538066177, topicName=职称评审)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Feb 17 08:02:00 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688544, encodeId=7a23168854438, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Wed Mar 21 00:02:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518309, encodeId=739a151830989, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Thu Feb 08 00:02:00 CST 2018, time=2018-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285628, encodeId=635a285628b8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Feb 06 09:15:07 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285625, encodeId=31ed28562588, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Feb 06 09:14:34 CST 2018, time=2018-02-06, status=1, ipAttribution=)]
    2018-02-08 xxxx1053
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032165, encodeId=251a203216551, content=<a href='/topic/show?id=25538066177' target=_blank style='color:#2F92EE;'>#职称评审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80661, encryptionId=25538066177, topicName=职称评审)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Feb 17 08:02:00 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688544, encodeId=7a23168854438, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Wed Mar 21 00:02:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518309, encodeId=739a151830989, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Thu Feb 08 00:02:00 CST 2018, time=2018-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285628, encodeId=635a285628b8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Feb 06 09:15:07 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285625, encodeId=31ed28562588, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Feb 06 09:14:34 CST 2018, time=2018-02-06, status=1, ipAttribution=)]
    2018-02-06 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2032165, encodeId=251a203216551, content=<a href='/topic/show?id=25538066177' target=_blank style='color:#2F92EE;'>#职称评审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80661, encryptionId=25538066177, topicName=职称评审)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Feb 17 08:02:00 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688544, encodeId=7a23168854438, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Wed Mar 21 00:02:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518309, encodeId=739a151830989, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Thu Feb 08 00:02:00 CST 2018, time=2018-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285628, encodeId=635a285628b8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Feb 06 09:15:07 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285625, encodeId=31ed28562588, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Feb 06 09:14:34 CST 2018, time=2018-02-06, status=1, ipAttribution=)]
    2018-02-06 神功盖世

    0

相关资讯

BCG绘中国社会办医前景图:近4000家公立医院要转制

不同种类、不同级别民营医院在数量上的悬殊指向一个结论——当下社会办医仍以规模小、技术能力不高的机构为主。随着政策向好、资金涌入、医生集团兴起,社会办医的角逐将更为激烈,怎样差异化发展才能生存?生存下来的医院又如何致胜?

江西公立医院经营不善 允许引入社会力量

江西省政府办公厅日前发文要求扩大市场开放,促进投资与合作。其中明确,经营不善的公立医院可采取改制、托管或公办民营等形式引入社会力量。

机会来了!国务院发文鼓励全科医生办诊所

国务院办公厅发布“关于改革完善全科医生培养与使用激励机制的意见”,到2020年,每万名居民拥有2—3名合格的全科医生。

蔡江南:社会办医的搅局式创新机遇来了!

我们国家目前大病小病都放在三级医院来做,就用了很重的模式,用搅局式的创新,可以把标准化的疾病、手术,不是疑难杂症,常见并、慢性病从三级医院剥离出来,费用低、靠近病人家庭方便,慢病采取网络的这个模式来做,这就是一种搅局式创新的做法。

2017年是社会办医硕果累累的一年

随着国家对社会办医越来越open的态度,无论数量规模还是质量都可谓是高歌猛进。过去的一年,社会办医具体都取得了哪些傲人的成绩,且看下面新鲜出炉的调研报告为您一一展示。

对标公立医院“心好累”?社会办医出路或在这里

取消两项审批政策即将落地上海试点,社会办医已然从大政方针渗透到实操层面,前途似乎一片光明。然而现实却是,尽管与公立医疗机构相比在绝对数量上占据优势,但在患者数量、床位数、医院评级等核心指标上,民营医疗机构仍处于绝对“劣势”。而近期广为流传的《基本医疗卫生与健康促进法》草案明确“禁止政府办公立医疗卫生机构与社会资本合作举办营利性机构”,似乎也使社会资本借力公立医疗机构的想法变得岌岌可危。社会办医下一

Baidu
map
Baidu
map
Baidu
map